The Department of Health Care Services posted the following alerts to the Medi-Cal Rx Web Portal:
- Medi-Cal Rx Weekly Wrap-Up for February 21-24 (February 25)
- Medi-Cal Rx Approved NDC List (February 25)
- Medi-Cal Rx Beneficiary Tips (February 28)
Also in California, the Board of Pharmacy published its March issue of “The Script.” This issue includes the following articles about:
- New pharmacy laws in 2022.
- Pharmacy issues related to COVID-19 vaccination programs.
- Mix-ups related to COVID-19 age requirements.
- A new vendor for submitting prescription data to CURES.
- A Board policy statement on compounding requirements.
- Mitigation strategies for preventing pharmacy drug diversion.
- The important role and responsibilities for pharmacists-in-charge.
- Listening sessions for pharmacy technicians.
- New public members appointed to the Board.
- New ad hoc committees on medication errors and workforce issues and on standard of care.
- Summaries of disciplinary actions ordered July 1 through December 31, 2021.
Also in California, the Office of Administrative Law has issued a Notice of Approval for amendments to the Code of Regulations’ Division 17 of Title 16, section 1715.6, related to Reporting Drug Loss, effective April 1.
Finally in California, the following Pharmacy Law waivers issued pursuant to Business and Professions Code section 4062 expired on February 28.
- Duty to Consult (Title 16, California Code of Regulations, section 1707.2(a))
- Prelicensure Inspection at Proposed Location of an Automated Drug Delivery System (ADDS) – Business and Professions Code sections 4119.11(a)(9) and BPC 4427.2(e)
- Signature Requirement for Receipt of Delivery of Drugs (BPC section 4059.5)
- Requirement for Consulting Pharmacist to Make Quarterly Visits to Clinic (BPC sections 4182(a) & (b)/BPC 4192(a) & (b))
Other waivers still in effect are posted online under Pharmacy Law Waivers.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.